migraines

The first oral version of a new class of migraine-prevention medicines has been approved by the FDA

Health & Wellbeing

New oral migraine prevention drug approved by FDA

Continuing the wave of cutting-edge new migraine drugs reaching the American market, the U.S. Food and Drug Administration (FDA) has now approved the first oral calcitonin gene-related peptide (CGRP) antagonist for acute migraine treatment.

Why are there so many conflicting studies about whether cannabis is an effective painkiller?

Health & Wellbeing

Cannabis and pain: New findings on headaches add a piece to the puzzle

New research is presenting evidence that cannabis can significantly reduce the severity of headaches and migraines. But the question remains: why are scientists coming up with such discordant results on whether cannabis can reduce pain?

As a wave of new migraine drugs begin to hit the market, some scientists are questioning how efficacious these new medicines are

Medical

Questions raised over efficacy of cutting-edge new migraine drugs

A study is reporting successful clinical trial results for a new orally administered iteration in a novel class of drugs designed to treat migraine, ahead of a potential FDA approval later this year. But some scientists are questioning how clinically useful these new migraine drugs actually are.

Researchers may have come up with a way to prevent the pain of migraines by flipping the polarization of electrical signals in affected brain cells

Medical

How migraines could be prevented by flipping electrical signals in the brain

For some migraine sufferers, the pain is preceded by visual artefacts called aura, triggered by a wave of electrical activity in the brain. Now researchers have found a way to counter and slow the spread of those signals, which could be the first step towards preventing or lessening migraines.

Aimovig is the first drug to reach the market that targets a specific receptor in the brain that can reduce the frequency of migraines

Health & Wellbeing

Cutting-edge migraine treatment cleared for public use by the FDA

After successful and safe clinical trials, the FDA has approved a first-of-its-kind migraine preventative medicine. It's the first in an entirely new class of drugs designed to block the activity of a specific peptide known to activate migraines that has been cleared for public use by the agency.

Several groundbreaking drugs to treat migraines are producing successful results in Phase 3 human clinical trials

Medical

Breakthrough migraine therapy cuts number of attacks in half

A new antibody treatment developed specifically for migraine prevention has just completed Phase III human clinical trials with remarkably positive results, raising hopes of a possible revolution on the horizon for sufferers of this debilitating condition.

In the US alone, over 37 million people suffer from migraines

Medical

In-ear device made to mitigate migraines

There may be new hope for migraine sufferers, in the form of a gadget that gets shoved up the ear. It alternately heats and cools the inside of the ear canal, and was recently shown to be effective in a study carried out by Britain's University of Kent.

The Nerivio device is worn on the outside of the upper arm

Health & Wellbeing

Wireless armband may be a headache for migraines

In recent years we've seen devices such as headbands that are designed to treat migraines. One of the latest such gadgets – which is worn on the arm like a blood pressure cuff – was recently the subject of a promising study.